Chase C. Leavitt - 25 May 2021 Form 3 Insider Report for Oncternal Therapeutics, Inc.

Role
General Counsel/Secretary
Signature
/s/Chase C. Leavitt
Issuer symbol
N/A
Transactions as of
25 May 2021
Net transactions value
$0
Form type
3
Filing time
27 May 2021, 18:06:16 UTC
Next filing
15 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ONCT Stock Options 25 May 2021 Common Stock 235,000 $6.76 Direct F1
holding ONCT Stock Options 25 May 2021 Common Stock 65,000 $6.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One quarter of the shares subject to the stock options shall vest on April 12, 2022, and the remaining shares subject to the option shall vest in 36 equal monthly installments over the three-year period thereafter, subject to the Reporting Person's continued employment or service with the Issuer on each such date.

Remarks:

Exhibit 24 - Power of Attorney